AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $25,805,000 | -12.4% | 10,934,154 | 0.0% | 0.18% | -7.4% |
| Q1 2019 | $29,468,000 | +24.8% | 10,934,154 | 0.0% | 0.19% | -2.1% |
| Q4 2018 | $23,618,000 | -26.3% | 10,934,154 | 0.0% | 0.19% | -8.5% |
| Q3 2018 | $32,037,000 | +10.6% | 10,934,154 | 0.0% | 0.21% | -3.2% |
| Q2 2018 | $28,976,000 | -81.2% | 10,934,154 | 0.0% | 0.22% | -83.3% |
| Q1 2018 | $153,953,000 | +19.7% | 10,934,154 | 0.0% | 1.30% | +17.0% |
| Q4 2017 | $128,586,000 | -17.1% | 10,934,154 | 0.0% | 1.12% | -11.4% |
| Q3 2017 | $155,156,000 | +0.9% | 10,934,154 | 0.0% | 1.26% | -6.5% |
| Q2 2017 | $153,844,000 | -15.7% | 10,934,154 | 0.0% | 1.34% | -9.9% |
| Q1 2017 | $182,491,000 | +4.9% | 10,934,154 | +3.8% | 1.49% | -12.4% |
| Q4 2016 | $173,951,000 | +23.6% | 10,536,092 | 0.0% | 1.70% | +33.5% |
| Q3 2016 | $140,762,000 | +174.3% | 10,536,092 | +35.9% | 1.28% | +137.4% |
| Q2 2016 | $51,321,000 | -24.9% | 7,752,487 | 0.0% | 0.54% | -25.4% |
| Q1 2016 | $68,377,000 | -18.8% | 7,752,487 | +14.9% | 0.72% | +3.3% |
| Q4 2015 | $84,207,000 | -11.3% | 6,747,332 | 0.0% | 0.70% | -20.4% |
| Q3 2015 | $94,935,000 | +1042.4% | 6,747,332 | +463.5% | 0.88% | +1101.4% |
| Q2 2015 | $8,310,000 | -14.9% | 1,197,366 | +0.8% | 0.07% | -9.9% |
| Q1 2015 | $9,763,000 | +7.5% | 1,187,666 | -1.9% | 0.08% | -12.9% |
| Q4 2014 | $9,078,000 | +12.5% | 1,210,350 | -0.1% | 0.09% | -8.8% |
| Q3 2014 | $8,071,000 | -28.9% | 1,211,851 | 0.0% | 0.10% | -26.6% |
| Q2 2014 | $11,355,000 | -26.4% | 1,211,851 | 0.0% | 0.14% | -29.1% |
| Q1 2014 | $15,427,000 | – | 1,211,851 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|